Viegas Susana, Ladeira Carina, Costa-Veiga Ana, Perelman Julian, Gajski Goran
1Environment and Health Research Group, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Av. Dom João II Lote 4.69.01, 1990-096 Lisboa, Portugal.
3Environment and Health Research Group, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Av. Dom João II Lote 4.69.01, 1990-096 Lisboa, Portugal.
Arh Hig Rada Toksikol. 2017 Dec 20;68(4):287-297. doi: 10.1515/aiht-2017-68-3005.
Cancer is one of the diseases of greatest concern in developed countries and much effort has been invested in discovering and developing therapeutics for curing cancer. Despite the improvements in antineoplastic therapeutics in the last decades, cancer is still one of the most harmful diseases worldwide. The global burden of cancer also implies financial costs: these can be direct costs, such as those related to treatment, care, and rehabilitation and indirect, which include the loss of economic output due to missed work (morbidity costs) and premature death (mortality costs). There are also hidden costs such as health insurance premiums and nonmedical expenses that are worth noting. This paper intends to present an overview of the generally forgotten impacts that the increasing number of cancer cases can have on the environment, workers who handle antineoplastic drugs, and health services. The knowledge available of each of the impacts will be addressed and discussed regarding the expected development. Overall, lessons learnt reflect on the impact of cancer through aspects not commonly evidenced in the literature or even considered in socio-economic analysis, in part due to the fact that these are difficult to contemplate in direct and indirect cancer costs already defined. Attention may be drawn to the need of continuous investment in prevention to reduce the negative impact on the environment, and in the health of workers who handle antineoplastic drugs for patients' treatment.
癌症是发达国家最受关注的疾病之一,人们在发现和开发癌症治疗方法方面投入了大量精力。尽管在过去几十年中抗肿瘤治疗有所改进,但癌症仍然是全球最具危害性的疾病之一。癌症的全球负担还意味着经济成本:这些成本可能是直接成本,如与治疗、护理和康复相关的成本,以及间接成本,包括因误工(发病成本)和过早死亡(死亡成本)导致的经济产出损失。还有一些隐性成本,如医疗保险费和非医疗费用也值得注意。本文旨在概述癌症病例不断增加可能对环境、接触抗肿瘤药物的工人以及医疗服务产生的通常被忽视的影响。将探讨和讨论关于每种影响的现有知识及其预期发展。总体而言,吸取的经验教训反映了癌症在文献中通常未得到充分证明甚至在社会经济分析中未被考虑的方面所产生的影响,部分原因是这些方面难以纳入已定义的癌症直接和间接成本中。可能需要关注持续投资于预防措施,以减少对环境以及为患者治疗而接触抗肿瘤药物的工人健康的负面影响。